Signal-averaged ECG prior to and serially after thrombolytic therapy for acute myocardial infarction

Area of Science:

• Cardiology
• Electrophysiology
• Myocardial Infarction Research

Background:

• Signal-averaged electrocardiograms (SAECGs) are used to assess late potentials after myocardial infarction (MI).
• Previous studies typically recorded SAECGs >12 hours post-MI.
• Early electrophysiological changes following thrombolytic therapy require further investigation.

Purpose of the Study:

• To investigate serial changes in SAECGs in patients receiving thrombolytic therapy for acute myocardial infarction.
• To evaluate early alterations in myocardial activation patterns within 7-10 days post-infarction.

Main Methods:

• SAECGs were recorded in 21 patients before and serially for 7-10 days after thrombolytic therapy.
• Key parameters analyzed included high-frequency QRS duration and terminal voltage.
• Ventricular late potentials were identified based on established criteria.

Main Results:

• High-frequency QRS duration significantly decreased at 1 and 24 hours post-therapy compared to baseline (P < 0.05).
• Terminal voltage increased significantly at 1 hour and 3 days post-therapy (P < 0.01).
• Ventricular late potentials were observed in 5 patients, more frequently in those with Q-wave MI or occluded arteries.

Conclusions:

• Early SAECG changes post-thrombolysis suggest dynamic myocardial activation related to ischemia and reperfusion.
• These transient changes may not directly correlate with the formation of a fixed substrate for ventricular arrhythmias.
• Serial SAECG monitoring provides insights into acute myocardial electrical remodeling.